Navigating the Intersection of Infection and Cancer: Addressing Tuberculosis in Migrant Populations – A Case Study and Epidemiological Review - Scorecard - MDSpire

Navigating the Intersection of Infection and Cancer: Addressing Tuberculosis in Migrant Populations – A Case Study and Epidemiological Review

  • By

  • Hans-Jörg Epple

  • Teresa Domaszewska

  • Ann-Christin von Brünneck

  • Christian Furth

  • Steffen Dommerich

  • Christoph Lange

  • Dinah von Schöning

  • Georg Maschmeyer

  • Lena Bös

  • Stefan Schwartz

  • Thomas Schneider

  • Stephan Mathas

  • December 23, 2025

  • 0 min

Share

Clinical Scorecard: Navigating the Intersection of Infection and Cancer: Addressing Tuberculosis in Migrant Populations – A Case Study and Epidemiological Review

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationMigrant populations from high TB incidence regions, particularly refugees.
Care Setting

Key Highlights

  • Importance of re-biopsy when initial pathology is inconsistent with clinical suspicion.

Guideline-Based Recommendations

Diagnosis

  • Utilize culture methods for TB detection
  • Consider re-biopsy if initial pathology is inconsistent with clinical suspicion
  • Screen for latent TB infection before initiating chemotherapy.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Individualized treatment adjustments based on drug tolerance, susceptibility, and patient-specific factors.

        Clinical Best Practices

        • Screen for latent TB infection in at-risk populations before starting immunosuppressive therapy
        • Use a combination of diagnostic methods for accurate TB detection
        • Follow WHO recommendations for TB treatment regimens
        • Adopt a multidisciplinary approach for managing TB in cancer patients.

        References

        Original Source(s)

        Navigating the Intersection of Infection and Cancer: Addressing Tuberculosis in Migrant Populations – A Case Study and Epidemiological Review

        • by Hans-Jörg Epple, Teresa Domaszewska, Ann-Christin von Brünneck, Christian Furth, Steffen Dommerich, Christoph Lange, Dinah von Schöning, Georg Maschmeyer, Lena Bös, Stefan Schwartz, Thomas Schneider, Stephan Mathas

        • December 23, 2025

        Related Content

        CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection

        An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model

        The Influence of National Antibiotic Consumption on Neisseria Gonorrhoeae Antibiotic Resistance in Norway, 2003–2024